Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Helmut Schumacher"'
Autor:
Michael Böhm, Helmut Schumacher, Christian Werner, Koon K. Teo, Eva M. Lonn, Felix Mahfoud, Thimoteus Speer, Giuseppe Mancia, Josep Redon, Roland E. Schmieder, Karen Sliwa, Nikolaus Marx, Michael A. Weber, Ulrich Laufs, Bryan Williams, Salim Yusuf, Johannes F. E. Mann
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Guidelines recommend physical activity to reduce cardiovascular (CV) events. The association between physical activity and progression of chronic kidney disease (CKD) with and without diabetes is unknown. We assessed the associati
Externí odkaz:
https://doaj.org/article/133765ddb7814fd4b8d24e2e745ab2b2
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Nocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than
Externí odkaz:
https://doaj.org/article/65c6f4a598e64122ab11ca4b987c8e1c
Publikováno v:
International Journal of Hypertension, Vol 2014 (2014)
Objective. To evaluate the efficacy and safety of the telmisartan plus amlodipine (T/A) single-pill combination (SPC) in Asian patients with hypertension whose blood pressure (BP) was not adequately controlled on either monotherapy or on low-dose com
Externí odkaz:
https://doaj.org/article/d741390d8da74a1a853f58c1a8b2fbf6
Publikováno v:
International Journal of Hypertension, Vol 2013 (2013)
Hypertensive patients unable to reach blood pressure (BP) targets with antihypertensive monotherapy may be switched to a combination of two medications with complementary modes of action for improved treatment response. This post hoc analysis pools d
Externí odkaz:
https://doaj.org/article/a689acb004c54f03b1022f4e4460637f
Publikováno v:
International Journal of Hypertension, Vol 2012 (2012)
Combination therapy is recommended for patients with blood pressure (BP) significantly above goal by recent consensus guidelines around the globe. The use of angiotensin II receptor blockers (ARBs) alone or in combination with a thiazide diuretic is
Externí odkaz:
https://doaj.org/article/6147846e3cd14f79b8c43c5ac8ee033f
Autor:
Hans-Juergen Lomp, Sylviane de Viron, Laura Trotta, Marc Buyse, Sebastiaan Höppner, Steve Young, Helmut Schumacher
Publikováno v:
Therapeutic Innovation & Regulatory Science
Background A central statistical assessment of the quality of data collected in clinical trials can improve the quality and efficiency of sponsor oversight of clinical investigations. Material and Methods The database of a large randomized clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c88495b1e9f863004cc0de4435a2ac
https://doi.org/10.1007/s43441-021-00341-5
https://doi.org/10.1007/s43441-021-00341-5
Autor:
Michael Böhm, Helmut Schumacher, Michael A. Weber, Eva Lonn, Giuseppe Mancia, Roland E. Schmieder, Felix Mahfoud, Karen Sliwa, Bryan Williams, Salim Yusuf, Johannes F.E. Mann, Nikolaus Marx, Josep Redon, Koon K. Teo
Publikováno v:
European Heart Journal. 40:2032-2043
Aims Studies have shown a non-linear relationship between systolic blood pressure (SBP) and diastolic blood pressure (DBP) and outcomes, with increased risk observed at both low and high blood pressure (BP) levels. We hypothesized that the BP-risk as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ee240f1f1a41ed0b02a5b0b4982484
https://doi.org/10.1093/eurheartj/ehz149
https://doi.org/10.1093/eurheartj/ehz149
Autor:
Salim Yusuf, Giuseppe Mancia, Johannes F.E. Mann, Roland E. Schmieder, Josep Redon, Michael Böhm, Eva Lonn, Koon K. Teo, Helmut Schumacher, Rita Facchetti
Publikováno v:
Journal of hypertension. 38(10)
AIMS There is conflicting evidence on whether in treated hypertensive patients the risk of renal outcomes is associated with visit-to-visit SBP variability. Furthermore, limited evidence is available on how important is SBP variability for prediction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47dbe4aa89e6e620b527ae37958aff30
https://pubmed.ncbi.nlm.nih.gov/32890282
https://pubmed.ncbi.nlm.nih.gov/32890282
Publikováno v:
ce/papers. 4:1-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a10dbdede9d5f1571a01ed7a82bb98f8
https://doi.org/10.1002/cepa.1240
https://doi.org/10.1002/cepa.1240
Autor:
Paolo Verdecchia, Helmut Schumacher, Michael Böhm, Josep Redon, Roland E. Schmieder, Giuseppe Mancia, Peter Sleight, Koon K. Teo, Salim Yusuf
Publikováno v:
Hypertension (Dallas, Tex. : 1979)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
In 28 790 patients recruited for the ONTARGET (Ongoing Treatment Alone and in Combination With Ramipril Global End Point Trials) and TRANSCEND (Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease) trials, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e177d433acb04bcc1ac361979c76f7fb
https://doi.org/10.1161/hypertensionaha.117.09714
https://doi.org/10.1161/hypertensionaha.117.09714